Ma L, Luan Y, Lu L
Cancer Med. 2025; 14(5):e70622.
PMID: 40062730
PMC: 11891933.
DOI: 10.1002/cam4.70622.
Shapiro R, Sheffer M, Booker M, Tolstorukov M, Birch G, Sade-Feldman M
J Hematol Oncol. 2025; 18(1):17.
PMID: 39948608
PMC: 11827236.
DOI: 10.1186/s13045-025-01669-3.
Armstrong S, Chen D, Kumar S, Heath J, Feinstein M, Greenland J
Int J Mol Sci. 2025; 26(3).
PMID: 39941136
PMC: 11818894.
DOI: 10.3390/ijms26031369.
He G, Jiang L, Zhou X, Gu Y, Tang J, Zhang Q
Front Immunol. 2024; 15:1494106.
PMID: 39737198
PMC: 11683592.
DOI: 10.3389/fimmu.2024.1494106.
Perumalsamy H, Xiao X, Han H, Oh J, Yoon S, Heo M
J Nanobiotechnology. 2024; 22(1):765.
PMID: 39696498
PMC: 11657454.
DOI: 10.1186/s12951-024-03036-9.
Interferon gamma-mediated prevention of tumor progression in a mouse model of multiple myeloma.
Kellermayer Z, Tahri S, de Jong M, Papazian N, Fokkema C, Stoetman E
Hemasphere. 2024; 8(12):e70047.
PMID: 39624831
PMC: 11609740.
DOI: 10.1002/hem3.70047.
Phenotypic and transcriptomic profiling of induced pluripotent stem cell (iPSC)-derived NK cells and their cytotoxicity against cancers.
Thongsin N, Suwanpitak S, Augsornworawat P, Srisantitham J, Saiprayong K, Jenjaroenpun P
Stem Cell Res Ther. 2024; 15(1):418.
PMID: 39533434
PMC: 11559060.
DOI: 10.1186/s13287-024-04029-z.
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells.
Bexte T, Albinger N, Al Ajami A, Wendel P, Buchinger L, Gessner A
Nat Commun. 2024; 15(1):8439.
PMID: 39349459
PMC: 11442982.
DOI: 10.1038/s41467-024-52388-1.
Bulk and single-cell transcriptomics identify gene signatures of stem cell-derived NK cell donors with superior cytolytic activity.
van Vliet A, van den Hout M, Steenmans D, Duru A, Georgoudaki A, de Gruijl T
Mol Ther Oncol. 2024; 32(4):200870.
PMID: 39346765
PMC: 11426129.
DOI: 10.1016/j.omton.2024.200870.
Application and research progress of single cell sequencing technology in leukemia.
Xie D, An B, Yang M, Wang L, Guo M, Luo H
Front Oncol. 2024; 14:1389468.
PMID: 39267837
PMC: 11390353.
DOI: 10.3389/fonc.2024.1389468.
Immunological characterization and comparison of children with COVID-19 from their adult counterparts at single-cell resolution.
Jia R, Li Z, Hu S, Chang H, Zeng M, Liu P
Front Immunol. 2024; 15:1358725.
PMID: 39148728
PMC: 11325098.
DOI: 10.3389/fimmu.2024.1358725.
Distinct granzyme k expression in immune cells: a single-cell rna-seq meta-analysis.
Kim H, Ha H
Genes Genomics. 2024; 46(9):1097-1106.
PMID: 39115674
DOI: 10.1007/s13258-024-01555-1.
Activation of non-classical Wnt signaling pathway effectively enhances HLA-A presentation in acute myeloid leukemia.
Ma Y, Yue J, Gao L, Zhou J, Chen W, Su J
Front Oncol. 2024; 14:1336106.
PMID: 38962268
PMC: 11219938.
DOI: 10.3389/fonc.2024.1336106.
High-dimensional single-cell analysis of human natural killer cell heterogeneity.
Rebuffet L, Melsen J, Escaliere B, Basurto-Lozada D, Bhandoola A, Bjorkstrom N
Nat Immunol. 2024; 25(8):1474-1488.
PMID: 38956378
PMC: 11291291.
DOI: 10.1038/s41590-024-01883-0.
Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing.
Zhou J, Chng W
Front Oncol. 2024; 14:1365330.
PMID: 38711849
PMC: 11070491.
DOI: 10.3389/fonc.2024.1365330.
Single-Cell Informatics for Tumor Microenvironment and Immunotherapy.
Tian J, Bai X, Quek C
Int J Mol Sci. 2024; 25(8).
PMID: 38674070
PMC: 11050520.
DOI: 10.3390/ijms25084485.
Fourteen years of cellular deconvolution: methodology, applications, technical evaluation and outstanding challenges.
Nguyen H, Nguyen H, Tran D, Draghici S, Nguyen T
Nucleic Acids Res. 2024; 52(9):4761-4783.
PMID: 38619038
PMC: 11109966.
DOI: 10.1093/nar/gkae267.
A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response.
Xu L, Saunders K, Huang S, Knutsdottir H, Martinez-Algarin K, Terrazas I
Cell Rep Med. 2024; 5(5):101511.
PMID: 38614094
PMC: 11148512.
DOI: 10.1016/j.xcrm.2024.101511.
The KIR2DL family serves as prognostic biomarkers and correlates with immune infiltrates in acute myeloid leukaemia.
Liu W, Zhu M, Li G, Xi Y
J Cell Mol Med. 2024; 28(8):e18256.
PMID: 38527290
PMC: 10963068.
DOI: 10.1111/jcmm.18256.
Uncovering the cellular and omics characteristics of natural killer cells in the bone marrow microenvironment of patients with acute myeloid leukemia.
Zhang L, Sun Y, Xue C, Wang S, Xu X, Zheng C
Cancer Cell Int. 2024; 24(1):106.
PMID: 38481242
PMC: 10938822.
DOI: 10.1186/s12935-024-03300-w.